CN106018655A - Method for detecting substances relevant with palbociclib raw material - Google Patents

Method for detecting substances relevant with palbociclib raw material Download PDF

Info

Publication number
CN106018655A
CN106018655A CN201610618387.6A CN201610618387A CN106018655A CN 106018655 A CN106018655 A CN 106018655A CN 201610618387 A CN201610618387 A CN 201610618387A CN 106018655 A CN106018655 A CN 106018655A
Authority
CN
China
Prior art keywords
mobile phase
solution
former times
volume
pabuk former
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610618387.6A
Other languages
Chinese (zh)
Other versions
CN106018655B (en
Inventor
丁青竹
刘斐
岳娟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Cuccess Pharmaceutical Co., Ltd.
Original Assignee
HEFEI YUANZHI PHARMACEUTICAL R & D Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEFEI YUANZHI PHARMACEUTICAL R & D Co Ltd filed Critical HEFEI YUANZHI PHARMACEUTICAL R & D Co Ltd
Priority to CN201610618387.6A priority Critical patent/CN106018655B/en
Publication of CN106018655A publication Critical patent/CN106018655A/en
Application granted granted Critical
Publication of CN106018655B publication Critical patent/CN106018655B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)

Abstract

The invention provides a method for detecting substances relevant with a palbociclib raw material. The method is carried out by virtue of a high performance liquid chromatography and comprises the following steps: (1) preparing a palbociclib sample solution; and (2) injecting the sample solution obtained in the step (1) into a high performance liquid chromatographic instrument, carrying out gradient elution by adopting a flow phase A and a flow phase B as flow phases, and recording a chromatogram map, wherein a fixed phase filler of a chromatographic column of the high performance liquid chromatography is fluobenzene-base bonded silica gel or benzene-base bonded silica gel, the prepared flow phase A is 0.05%-0.3% deionized water solution, and the volume ratio of acidy buffer liquid to methanol is (0-10) to (90-100) in the prepared flow phase B. According to the method, the substances relevant with the palbociclib raw material can be detected under the same liquid phase. The method has the advantages that the operation is simple and convenient, the separation degree is high, the specificity is strong, and the detection result is accurate and credible.

Description

A kind of Pabuk former times profit cloth raw material has the detection method of related substance
Technical field
The invention belongs to pharmaceutical analysis field.Specifically, the present invention relates to a kind of employing high effective liquid chromatography for measuring Pabuk former times profit cloth raw material has the detection method of related substance.
Technical background
Pabuk former times profit cloth (Palbociclib) is that a kind of height researched and developed by Pfizer pharmaceutical Co. Ltd is selective thin Born of the same parents cyclin-dependent kinase CDK4 and CDK6 reversibility antagonist.Its chemical entitled 6-acetyl group-8-cyclopenta-5-first Base-2-{ [5-(1-piperazinyl)-2-pyridine radicals] amino }-7,8-dihydroquinazoline-7-ketone, the entitled 6-acetyl-of English language Chemical 8-cyclopentyl-5-methyl-2 - {[5- (1-piperazinyl) -2-pyridinyl] amino} -7,8- Dihydro-quinazolin-7 ketone, its molecular weight is 447.53, and molecular formula is C24H29N7O2
Pabuk former times profit cloth can block cell cycle from the G1 phase to the process of S phase by suppression CDK4/6, thus suppresses DNA to close Become.Preclinical study data show, Palbociclib has tumor cell and subtracts the effect of going out and cell growth inhibiting effect, is First Breast cancer immunotherapy medicine of the listing at present ratified by FDA for 2015, the most above-mentioned (advises for conventional capsule agent Lattice 75mg, 100mg and 125mg).
Breast carcinoma be breast glandular epithelium under multiple cancerigenic factor effect, producer suddenly change, cause normal cell Become cancerous cell.The pernicious increment of cancerous cell makes the normal configuration of mammary gland tissue be destroyed, and extrudes and corrodes normal structure.Breast Adenocarcinoma is one of modal malignant tumor of women (male rare but exist), is only second to uterus carcinoma, and it is the most diffusible arrives other Position, is also the major disease that serious harm patient is physically and mentally healthy, increase society's medical burden.
The early treatment of breast carcinoma includes operative treatment, endocrine therapy, chemotherapy, radiotherapy and molecular targeted therapy, although So, still having a lot of patient that transfer and recurrence can occur, its main mechanism includes tumor drug resistance, the activation of signal path and cancer base The activation etc. of cause.At present, the relation of tumor microenvironment and host is paid close attention in more research, and wherein immune system is important composition One of part.Therefore for the immune system of patient, breast is become by regulating its effect in tumor is alleviation and host The foundation of adenocarcinoma successive treatment.Pabuk former times profit cloth blocks cell cycle from the G1 phase to the process of S phase by suppression CDK4/6, thus The synthesis of suppression DNA.Its preclinical test data show that Pabuk former times profit cloth has tumor cell and subtracts the effect of going out and suppression cell life Long effect.
At present in Pabuk former times profit cloth Material synthesis technique, the initiation material that may contain in final raw produce, intermediate And the known impurities of degraded has 7, respectively 4-(6-aminopyridine-3-base) piperazine-1-carboxylic acid tert-butyl ester (SM1), 6-are bromo- 2-chloro-8-cyclopenta-5-methvl-pyridinium also [2,3-D] pyrimidine-7 (8H)-one (SM2), tert-butyl group 4-(6-(6-bromo-8-ring penta Base-5-methyl-7-oxygen-7,8-dihydropyridine [2,3-d] pyrimidine-2-yl amino) pyridine-3-yl) piperazine-1-carboxylate (PALB01), tert-butyl group 4-(6-(6-(1-vinyl butyl ether)-8-cyclopenta-5-methyl-7-oxygen-7,8-dihydropyridine [2,3- D] pyrimidine-2-yl amino) pyridine-3-yl) piperazine-1-carboxylate (PALB02), 8-cyclopenta-5-methyl-2-((5-(piperazine Piperazine-1-base) pyridine-2-base) amino)-6-vinylpyridine also [2,3-d] pyrimidine-7(8H)-ketone (PF-06651464), 8- Cyclopenta-5-methyl-2-(5-piperazine-1-base-pyridine-2-base amino)-8H-pyrido [2,3-d] pyrimidin-7-ones (PF- 00447880), 4-[6-(6-acetyl group-8-cyclopenta-5-methyl-7-oxo-7,8-dihydro pyrido [2,3-d] pyrimidine-2- Base amino)-pyridin-3-yl]-piperazine-1-carboxylate (PF-00310864).
A kind of Pabuk former times profit cloth raw material involved in the present invention have the detection method of related substance be primarily directed to above wherein Pabuk former times profit cloth known impurities effectively detects and separates.Wherein, 4-(6-aminopyridine-3-base) piperazine-1-carboxylic acid uncle The bromo-2-of butyl ester, 6-chloro-8-cyclopenta-5-methvl-pyridinium also [2,3-D] pyrimidine-7 (8H)-one is initiation material;Tert-butyl group 4- (6-(6-bromo-8-cyclopenta-5-methyl-7-oxygen-7,8-dihydropyridine [2,3-d] pyrimidine-2-yl amino) pyridine-3-yl) piperazine Piperazine-1-carboxylate, tert-butyl group 4-(6-(6-(1-vinyl butyl ether)-8-cyclopenta-5-methyl-7-oxygen-7,8-dihydropyridine [2, 3-d] pyrimidine-2-yl amino) pyridine-3-yl) piperazine-1-carboxylate is synthetic intermediate;8-cyclopenta-5-methyl-2- ((5-(piperazine-1-base) pyridine-2-base) amino)-6-vinylpyridine also [2,3-d] pyrimidine-7(8H)-ketone, 8-cyclopenta- 5-methyl-2-(5-piperazine-1-base-pyridine-2-base amino)-8H-pyrido [2,3-d] pyrimidin-7-ones, 4-[6-(6-second Acyl group-8-cyclopenta-5-methyl-7-oxo-7,8-dihydro pyrido [2,3-d] pyrimidine-2--amino)-pyridin-3-yl]- Piperazine-1-carboxylate is catabolite.
At present, Chinese Pharmacopoeia and foreign pharmacopeia do not include Pabuk former times profit cloth raw material relevant substance-measuring method.Disclosed Patent in, not inquiring the relevant testing conditions having related substance.Chinese patent application CN 105541832 A discloses one The preparation method of isethionate Pabuk former times profit cloth, another Chinese patent application CN 105418603 A disclose a kind of high-purity Degree Pabuk former times profit cloth and the preparation method of reaction intermediate, Chinese patent CN 105748435 A disclose a kind of Pabuk former times profit Cloth pharmaceutical composition and preparation method thereof, Chinese patent CN 104887641 A disclose a kind of Pabuk former times profit cloth intra-gastric floating tablet And preparation method thereof.Above four four patents the Pabuk former times profit relevant substance detecting method of cloth crude drug is not carried out research and Illustrate.Additionally, in PCT Patent Application WO/2016/0662420A1, WO/2016/0662429A1, US20160024084 etc. Pabuk former times profit cloth crude drug relevant substance-measuring method is not studied.Detection method provided by the present invention can be to above-mentioned One or more in seven kinds of impurity effectively detect.
Summary of the invention
It is an object of the invention to provide a kind of employing high effective liquid chromatography for measuring Pabuk former times profit cloth crude drug and have related substance Detection method, thus accurate and effective measures and has related substance, precisely control product quality in Pabuk former times profit cloth raw material.
For above-mentioned purpose, the present invention provides technical scheme as follows:
The present invention provides a kind of Pabuk former times profit to be furnished with the detection method of related substance, and wherein said Pabuk former times profit is furnished with related substance and includes 4-(6-aminopyridine-3-base) piperazine-1-carboxylic acid tert-butyl ester, the bromo-2-of 6-chloro-8-cyclopenta-5-methvl-pyridinium also [2,3-D] Pyrimidine-7 (8H)-one, tert-butyl group 4-(6-(6-bromo-8-cyclopenta-5-methyl-7-oxygen-7,8-dihydropyridine [2,3-d] pyrimidine- 2-yl amino) pyridine-3-yl) piperazine-1-carboxylate, tert-butyl group 4-(6-(6-(1-vinyl butyl ether)-8-cyclopenta-5-first Base-7-oxygen-7,8-dihydropyridine [2,3-d] pyrimidine-2-yl amino) pyridine-3-yl) piperazine-1-carboxylate is, 8-cyclopenta- 5-methyl-2-((5-(piperazine-1-base) pyridine-2-base) amino)-6-vinylpyridine also [2,3-d] pyrimidine-7(8H)- Ketone, 8-cyclopenta-5-methyl-2-(5-piperazine-1-base-pyridine-2-base amino)-8H-pyrido [2,3-d] pyrimidin-7-ones, 4-[6-(6-acetyl group-8-cyclopenta-5-methyl-7-oxo-7,8-dihydro pyrido [2,3-d] pyrimidine-2--amino)-pyrrole Pyridine-3-base] one or more in-piperazine-1-carboxylate, the method is to use high performance liquid chromatography to carry out , comprise the steps:
(1) preparation Pabuk former times profit cloth sample solution, described Pabuk former times profit cloth sample solution includes need testing solution;
(2) step (1) gained sample solution is injected high performance liquid chromatograph, use mobile phase A and Mobile phase B as flowing phase Carry out gradient elution, and record chromatogram;
Wherein, the preparation method of described need testing solution comprises the steps: that precision weighs Pabuk former times profit cloth crude drug sample, adds Diluent dissolves and is diluted to the concentration of Pabuk former times profit cloth is 0.2mg/ml~2mg/ml, obtains need testing solution;
The chromatographic column fixed phase filler of described high performance liquid chromatography is fluorophenyl interval silica gel or phenyl bonded silica, preferably Fixing phase filler is fluorophenyl bonded silica gel.
The preparation method of described impurity sample-adding solution comprises the steps: that precision weighs Pabuk former times profit cloth reference substance, adds dilute Releasing liquid and dissolving and be diluted to the concentration of Pabuk former times profit cloth is 20ug/ml~5mg/ml, obtains Pabuk former times profit cloth reference substance deposit Liquid;Separately take 4-(6-aminopyridine-3-base) piperazine-1-carboxylic acid tert-butyl ester, the bromo-2-of 6-chloro-8-cyclopenta-5-methyl-pyrrole respectively Pyridine also [2,3-D] pyrimidine-7 (8H)-one, tert-butyl group 4-(6-(6-bromo-8-cyclopenta-5-methyl-7-oxygen-7,8-dihydropyridine [2,3-d] pyrimidine-2-yl amino) pyridine-3-yl) piperazine-1-carboxylate, tert-butyl group 4-(6-(6-(1-vinyl butyl ether)-8- Cyclopenta-5-methyl-7-oxygen-7,8-dihydropyridine [2,3-d] pyrimidine-2-yl amino) pyridine-3-yl) piperazine-1-carboxylate For, 8-cyclopenta-5-methyl-2-((5-(piperazine-1-base) pyridine-2-base) amino)-6-vinylpyridine also [2,3-d] is phonetic Pyridine-7(8H)-ketone, 8-cyclopenta-5-methyl-2-(5-piperazine-1-base-pyridine-2-base amino)-8H-pyrido [2,3- D] pyrimidin-7-ones, 4-[6-(6-acetyl group-8-cyclopenta-5-methyl-7-oxo-7,8-dihydro pyrido [2,3-d] pyrimidine- 2-base amino)-pyridin-3-yl]-piperazine-1-carboxylate's standard substance, accurately weighed, dissolve also with diluent respectively Being diluted to concentration is 20ug/ml~5mg/ml, obtains each impurity reference substance solution mother solution;Precision measures Pabuk former times Li Buduo photo Storing solution and Pabuk former times profit cloth each impurity reference substance mother solution, mixing, add diluted, obtain Pabuk former times profit cloth impurity sample-adding molten Liquid;
Preferably, wherein said diluent is water: acetonitrile: perchloric acid=60:40:0.05.
Preferably, wherein the concentration of Pabuk former times profit cloth is 1.0mg/ml in Pabuk former times profit cloth need testing solution.
Preferably, wherein Pabuk former times profit cloth each impurity reference substance mother liquid concentration is 100ug/ml.
Preferably, in high performance liquid chromatography detecting step (2), first own control solution is injected liquid chromatograph Instrument, first injects chromatograph of liquid by contrast solution, regulates detection sensitivity, and the peak height making main constituent chromatographic peak is full scale 20%;Again need testing solution and impurity are loaded solution and are injected separately into chromatograph of liquid, use mobile phase A and Mobile phase B as stream Move and carry out gradient elution mutually, and record chromatogram;Preferably, the amount of sample solution in chromatograph of liquid of injecting is 2ul.
The detection method of the present invention measures under same liquid-phase condition has related substance, described inspection in Pabuk former times profit cloth raw material Survey method is easy and simple to handle, and Pabuk former times profit cloth main peak retention time is more suitable, and wherein an impurity all can effectively be detected, point From degree height, assay method specificity is strong, and testing result is the most credible, for quality control, the impurity research of Pabuk former times profit cloth raw material Provide a kind of easy reasonably detection method.The inventive method has the mensuration of related substance be applicable to Pabuk former times profit cloth crude drug And sample survey.
Detailed description of the invention
The following example is the present invention to be explained further and illustrates, but is not intended to it and limits this by any way Bright scope.
By great many of experiments and exploration, the Pabuk former times profit cloth raw material of the present invention has the detection method of related substance effectively to divide From the relative seven kinds of known impurities of Pabuk former times profit cloth, method is reliable, measures accurately.
Embodiment 1
The Pabuk former times profit relevant substance detecting method of cloth raw material of the present invention
1. detecting instrument and testing conditions
Instrument: wear peace Ultimate3000;Wear peace VWD-3100
Chromatographic column: fluorobenzene pilum (1.7um, 2.1mm × 100mm)
Flowing phase: A:0.05%(v/v) high chloro acid solution
B: methanol
Flow velocity: 0.4ml/min;Detection wavelength: 220nm;
Column temperature: 55 DEG C;Automatic sampler temperature is 25 DEG C.
2. solution preparation: take Pabuk former times profit cloth material sample, adds diluent dissolving and makes every 1ml containing about Pabuk former times profit cloth The need testing solution of 1mg.
Precision measures need testing solution 1ml, puts in 100ml volumetric flask, is diluted to scale by mobile phase A, shakes up, as certainly Body contrast solution.
Take Pabuk former times profit cloth reference substance about 100mg, put in 50ml measuring bottle, dissolve with diluent and be diluted to scale, shake up, It is Pabuk former times profit cloth reference substance storing solution;Separately take SM1, SM2, PALB01, PALB02, PF-06651464, PF-respectively 00447880, each 10mg of PF-00310864 standard substance, accurately weighed, puts in 10ml measuring bottle, dissolves with diluent and is diluted to carve Degree, shakes up, is each dirt solution mother solution;Precision measures Pabuk former times profit cloth reference substance storing solution 5.0ml and each dirt solution is female Liquid 1.0ml, puts in 10ml measuring bottle and mixes, by diluted to scale, shake up, and is worth Pabuk former times profit cloth impurity sample-adding solution.
3. assay method: go own control solution 2ul to inject chromatograph of liquid, regulate detection sensitivity, make main constituent color The peak height of spectral peak is about the 20% of monitor full scale.Separately take need testing solution and the impurity sample-adding each 2ul of solution injects liquid chromatograph Instrument, carries out gradient elution, 3 ~ 4 times of record chromatogram to main constituent peak retention time according to table 1.
The present invention is easy and simple to handle, and Pabuk former times profit cloth main peak retention time is about about 11 minutes, and the detection time is more suitable, Seven kinds of known impurities all can effectively be detected, and separating degree all meets the requirements (more than 1.5), and assay method specificity is strong, inspection Survey result the most credible.

Claims (10)

1. the detection method having related substance in Pabuk former times profit cloth raw material, relevant in wherein said Pabuk former times profit cloth raw material Material include PF-00447880, PF-06651464, PF-00310864 one or more, the method be use high-efficient liquid phase color Spectrometry is carried out, and comprises the steps:
(1) preparation Pabuk former times profit cloth sample solution, described Pabuk former times profit cloth sample solution includes need testing solution;
(2) step (1) gained sample solution is injected high performance liquid chromatograph, use mobile phase A and Mobile phase B as flowing Carry out gradient elution mutually, and record chromatogram;
Wherein, the preparation method of described need testing solution comprises the steps: that precision weighs Pabuk former times profit cloth material sample, adds dilute Releasing liquid and dissolving and be diluted to the concentration of Pabuk former times profit cloth is 0.2mg/ml~2.0mg/ml, obtains need testing solution;
The chromatographic column fixed phase filler of described high performance liquid chromatography is fluorophenyl bonded silica gel or phenyl bonded silica, preferably Fixing phase filler is fluorophenyl bonded silica gel;
Mobile phase A be formulated as 0.05% ~ 0.5% acidic buffer;The acidic buffer of the preparation 0.05% ~ 0.3% of Mobile phase B Liquid amasss: methanol volume=0 ~ 10:100 ~ 90.
2. according to the detection method described in claim 1, wherein mobile phase A be formulated as 0.05% acidic buffer.
3. according to the detection method described in claim 1 or 2, wherein Mobile phase B be formulated as 0.05% buffer volume: first Alcohol volume=0:100.
4., according to the detection method according to any one of claim 3, the gradient elution of wherein said high performance liquid chromatography is suitable Sequence is as follows:
When 0 minute, flowing is mutually: 90~100 volume % mobile phase A+0~10 volume % Mobile phase B;
When 0-30 minute, flowing is mutually: 45~55 volume % mobile phase A+45~55 volume % Mobile phase B;
When 30-45 minute, flowing is mutually: 0~10 volume % mobile phase A+90~100 volume % Mobile phase B;
When 45-55 minute, flowing is mutually: 90~100 volume % mobile phase A+0~10 volume % Mobile phase B;
Preferably, the gradient elution order of described high performance liquid chromatography is as follows:
When 0 minute, flowing is mutually: 97 volume % mobile phase A+3 volume % Mobile phase B;
When 0-30 minute, flowing is mutually: 50 volume % mobile phase A+50 volume % Mobile phase B;
When 30-45 minute, flowing is mutually: 3 volume % mobile phase A+97 volume % Mobile phase B;
During 45-55 minutes, flowing is mutually: 97 volume % mobile phase A+3 volume % Mobile phase B.
5., according to the detection method according to any one of claim 1 to 4, the acid of wherein said acidic buffer is high chlorine Acid, phosphoric acid, trifluoroacetic acid, preferably perchloric acid;
Preferably, the concentration of acidic buffer is 0.05% ~ 0.3%(v/v), preferably 0.05%;
Preferably, the pH of acidic buffer is 2.0 ~ 7.0, and the pH of the phase that preferably flows is 2.3;
Preferably, the flow velocity of flowing phase is 0.3~0.5ml/min, and the flow velocity of the phase that preferably flows is 0.4ml/min.
6. according to the detection method according to any one of claim 1 to 5, the chromatograph of wherein said high performance liquid chromatography Post column temperature is 40~65 DEG C, preferably 55 DEG C;
Preferably, auto injection room temperature is 4 ~ 30 DEG C, preferably 25 DEG C;
Preferably, detection wavelength is 220nm.
7., according to the detection method according to any one of claim 1 to 6, wherein said Pabuk former times profit cloth sample solution also wraps Include own control solution and/or impurity sample-adding solution;
The preparation method of described own control solution comprises the steps: that precision measures need testing solution 1ml, puts 100ml capacity In Ping, add diluted to scale, shake up, obtain own control solution;
The preparation method of described impurity sample-adding solution comprises the steps: that precision weighs Pabuk former times profit cloth reference substance, adds diluent Dissolving and being diluted to the concentration of Pabuk former times profit cloth is 0.2mg/ml~2mg/ml, obtains Pabuk former times profit cloth reference substance storing solution; Separately take PF-00447880, PF-06651464, PF-00310864 respectively, accurately weighed, dissolve with diluent respectively and be diluted to Concentration is 20ug/ml~5mg/ml, obtains each impurity reference substance solution mother solution;Precision measures Pabuk former times profit cloth reference substance deposit Liquid and Pabuk former times Li Butan each impurity reference substance solution mother solution, mixing, add diluted, obtain Pabuk former times profit cloth impurity sample-adding Solution;
Preferably, wherein said diluent is water: acetonitrile: perchloric acid=60:40:0.05.
8. according to the detection method according to any one of claim 1 to 7, wherein Pabuk in Pabuk former times profit cloth need testing solution Former times profit cloth concentration is 1mg/ml.
9. according to the detection method described in claim 7 or 8, wherein Pabuk former times profit cloth each impurity reference substance solution mother liquid concentration It is 100 μ g/ml.
10. according to the detection method according to any one of claim 7 to 9, wherein, at high performance liquid chromatography detecting step (2) in, first sample own control solution is injected chromatograph of liquid, regulate detector sensitivity, make main constituent chromatographic peak Peak height is the 20% of monitor full scale;Again need testing solution and impurity are loaded solution and are injected separately into chromatograph of liquid, use Mobile phase A carries out gradient elution with Mobile phase B mutually as flowing, and records chromatogram;Preferably, inject in chromatograph of liquid The amount of sample solution is 2 μ l.
CN201610618387.6A 2016-08-01 2016-08-01 A kind of detection method of the Pabuk former times profit cloth raw material about material Active CN106018655B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610618387.6A CN106018655B (en) 2016-08-01 2016-08-01 A kind of detection method of the Pabuk former times profit cloth raw material about material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610618387.6A CN106018655B (en) 2016-08-01 2016-08-01 A kind of detection method of the Pabuk former times profit cloth raw material about material

Publications (2)

Publication Number Publication Date
CN106018655A true CN106018655A (en) 2016-10-12
CN106018655B CN106018655B (en) 2018-01-19

Family

ID=57114428

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610618387.6A Active CN106018655B (en) 2016-08-01 2016-08-01 A kind of detection method of the Pabuk former times profit cloth raw material about material

Country Status (1)

Country Link
CN (1) CN106018655B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106970177A (en) * 2017-06-06 2017-07-21 北京元延医药科技股份有限公司 The analyzing detecting method of Pa Boxini intermediates and its impurity
CN111239299A (en) * 2020-03-30 2020-06-05 重庆三圣实业股份有限公司 Method for separating and measuring palbociclib and impurities thereof
CN114544847A (en) * 2022-03-09 2022-05-27 上海皓元医药股份有限公司 Method for detecting genotoxic impurities in starting raw material for synthesizing thuja occidentalis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104892604A (en) * 2015-06-19 2015-09-09 北京康立生医药技术开发有限公司 Novel synthesis method of CDK4 (cyclin-dependent kinase 4) inhibitor
WO2016030439A1 (en) * 2014-08-28 2016-03-03 Ratiopharm Gmbh Method of producing palbociclib and pharmaceutical compositions comprising the same
CN105418603A (en) * 2015-11-17 2016-03-23 重庆莱美药业股份有限公司 Method for preparing high-purity palbociclib and reaction intermediate of palbociclib
CN105524059A (en) * 2016-01-06 2016-04-27 北京修正创新药物研究院有限公司 Palbociclib impurity preparation method

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016030439A1 (en) * 2014-08-28 2016-03-03 Ratiopharm Gmbh Method of producing palbociclib and pharmaceutical compositions comprising the same
CN104892604A (en) * 2015-06-19 2015-09-09 北京康立生医药技术开发有限公司 Novel synthesis method of CDK4 (cyclin-dependent kinase 4) inhibitor
CN105418603A (en) * 2015-11-17 2016-03-23 重庆莱美药业股份有限公司 Method for preparing high-purity palbociclib and reaction intermediate of palbociclib
CN105524059A (en) * 2016-01-06 2016-04-27 北京修正创新药物研究院有限公司 Palbociclib impurity preparation method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SHENGQUAN DUAN ET AL: "Palbociclib Commercial Manufacturing Process Development. Part I: Control of Regioselectivity in a Grignard-Mediated SNAr Coupling", 《ORGANIC PROCESS RESEARCH & DEVELOPMENT》 *
袁铎 等: "Palbociclib有关物质的分析及合成", 《中国药科大学学报》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106970177A (en) * 2017-06-06 2017-07-21 北京元延医药科技股份有限公司 The analyzing detecting method of Pa Boxini intermediates and its impurity
CN111239299A (en) * 2020-03-30 2020-06-05 重庆三圣实业股份有限公司 Method for separating and measuring palbociclib and impurities thereof
CN111239299B (en) * 2020-03-30 2022-05-27 重庆三圣实业股份有限公司 Method for separating and measuring palbociclib and impurities thereof
CN114544847A (en) * 2022-03-09 2022-05-27 上海皓元医药股份有限公司 Method for detecting genotoxic impurities in starting raw material for synthesizing thuja occidentalis
CN114544847B (en) * 2022-03-09 2023-11-03 上海皓元医药股份有限公司 Method for detecting genotoxic impurities in starting raw material for synthesizing piperaquine Bai Xi

Also Published As

Publication number Publication date
CN106018655B (en) 2018-01-19

Similar Documents

Publication Publication Date Title
CN106970177B (en) The analyzing detecting method of Pa Boxini intermediates and its impurity
CN104655751B (en) A kind of detect the method for organic solvent residual in dapoxetine
Germann et al. Risperidone
CN103864819B (en) A kind of ceftazidime compound and pharmaceutical composition thereof
CN108828127A (en) Liquid-phase chromatography method in relation to substance in a kind of detection Parecoxib Sodium and synthetic intermediate
CN106018655A (en) Method for detecting substances relevant with palbociclib raw material
EP3730935A1 (en) Method for detecting trifluridine- and/or tipiracil-derived analogs
CN102375033B (en) High performance liquid chromatographic analysis method of bendamustine hydrochloride and its related substances
CN105017243B (en) A kind of Ceftriaxone Sodium Photodegradation Products and preparation method thereof and analyzing detecting method
Altine et al. Preclinical evaluation of a Fluorine-18 (18F)-labeled phosphatidylinositol 3-kinase inhibitor for breast cancer imaging
CN104515816B (en) The detection method of a kind of ambrisentan raw material and preparation related substance
CN102338782B (en) Fresh animal medicinal composition and method for measuring content of Chinese medicines of fresh animal medicinal composition
Shi et al. Development and validation of method for the determination of related substances of tacrolimus in tacrolimus capsules and degradation studies
CN109521117A (en) A kind of detection method of the ibuprofen injection in relation to substance
CN106290657B (en) A kind of method for detecting impurity in Desloratadine
CN106290600B (en) A method of with liquid chromatography, separation health Buddhist nun replaces Buddhist nun and related substance
CN107422055A (en) The detection method of impurity in a kind of Risperidone raw material or preparation
Sikora et al. Disproportionation of clozapine radical: a link between one-electron oxidation of clozapine and formation of its nitrenium cation
Al-Omar Ofloxacin
CN106153756B (en) High performance liquid chromatography for detecting rapamycin in everolimus
CN102928525A (en) Method for detecting related substance II of cefpirome in cefpirome sulfate/sodium chloride injection
CN113109467A (en) Method for determining in-vitro dissolution of nifedipine sustained-release tablets
CN102109501B (en) Method for detecting related substances in quinapril hydrochloride and hydrochlorothiazide composition
CN105806985B (en) A kind of assay method of vomiting nut aglycon biological sample
CN112816570B (en) Method for detecting azithromycin related substances

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20170801

Address after: 210038 Nanjing economic and Technological Development Zone, Jiangsu, No. 20 Xingang Avenue

Applicant after: Nanjing Cuccess Pharmaceutical Co., Ltd.

Address before: High tech Zone camphor road in Hefei city Anhui province 230001 No. 168 Technology Industrial Park building D17/22

Applicant before: HEFEI YUANZHI PHARMACEUTICAL R & D CO., LTD.

GR01 Patent grant
GR01 Patent grant